Evidence map›Paper›PMID 25914451›Full record

ReviewWorld journal of gastroenterology2015

Treatment of esophagogastric junction carcinoma: an unsolved debate.

Michele Orditura, Gennaro Galizia, Eva Lieto, Ferdinando De Vita, Fortunato Ciardiello

Abstract readEditorialReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michele OrdituraMichele Orditura, Ferdinando De Vita, Fortunato Ciardiello, Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi", School of Medicine, Second University of Naples, 80131 Naples, Italy.
Gennaro GaliziaMichele Orditura, Ferdinando De Vita, Fortunato Ciardiello, Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi", School of Medicine, Second University of Naples, 80131 Naples, Italy.
Eva LietoMichele Orditura, Ferdinando De Vita, Fortunato Ciardiello, Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi", School of Medicine, Second University of Naples, 80131 Naples, Italy.
Ferdinando De VitaMichele Orditura, Ferdinando De Vita, Fortunato Ciardiello, Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi", School of Medicine, Second University of Naples, 80131 Naples, Italy.
Fortunato CiardielloMichele Orditura, Ferdinando De Vita, Fortunato Ciardiello, Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi", School of Medicine, Second University of Naples, 80131 Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of esophagogastric junction adenocarcinoma (AEG) is increasing worldwide. Barrett's esophagus (BE) associated with dysplasia is the main risk factor for the development of cancer. Currently, screening programs to individuate and eradicate BE represent the best way to reduce AEG cancer. Several endoscopic approaches are here discussed. Surgical strategies for different types of AEG cancer are now fairly standardized, and multidisciplinary strategies using chemotherapy or chemoradiotherapy may improve the outcome of these patients. Here we briefly discuss the keypoints, main topics, and critical issues, according to accumulating evidence and taking into account our own experience.

Indexed as

EsophagectomyAdenocarcinomaBarrett EsophagusChemoradiotherapy, AdjuvantChemotherapy, AdjuvantEsophageal NeoplasmsEsophagogastric JunctionHumansNeoadjuvant TherapyRisk FactorsStomach NeoplasmsTreatment OutcomeBarrett’s esophagusChemoradiotherapyChemotherapyEndoscopic resectionEsophagogastric junction adenocarcinomaSurgery

Identifiers

PMID25914451
PMCPMC4402289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.